ArticleBioscience reports2020

NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/IL-1β/Wnt/β-catenin signaling pathway.

Qiao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.